Assignee
ERRANT GENE THERAPEUTICS LLC
US·10 granted patents·1 pending application·52 citations·filing 2001–2009
Top patents by PatentIndex Score
11 records- 0192US7842727B2Histone deacetylase inhibitorsERRANT GENE THERAPEUTICS LLC·Filed 2006·Granted Nov 30, 2010·8 cites·1 claims
- 0282US7314953B2Treatment of lung cells with histone deacetylase inhibitorsERRANT GENE THERAPEUTICS LLC·Filed 2003·Granted Jan 1, 2008·15 cites·27 claims
- 0382US7312247B2Histone deacetylase inhibitorsERRANT GENE THERAPEUTICS LLC·Filed 2001·Granted Dec 25, 2007·11 cites·11 claims
- 0475US8026280B2Histone deacetylase inhibitorsERRANT GENE THERAPEUTICS LLC·Filed 2001·Granted Sep 27, 2011·5 cites·36 claims
- 0575US7214831B2Histone deacetylase inhibitors based on alpha-chalcogenmethylcarbonyl compoundsERRANT GENE THERAPEUTICS LLC·Filed 2003·Granted May 8, 2007·7 cites·32 claims
- 0672US2010234455A1Histone Deacetylase InhibitorsERRANT GENE THERAPEUTICS LLC·Filed 2009·Application pending·0 cites
- 0769US7057057B2Histone deacetylase inhibitors based on alpha-ketoepoxide compoundsERRANT GENE THERAPEUTICS LLC·Filed 2003·Granted Jun 6, 2006·3 cites·28 claims
- 0866US7858664B2Histone deacetylase inhibitorsERRANT GENE THERAPEUTICS LLC·Filed 2004·Granted Dec 28, 2010·1 cites·1 claims
- 0960US7902259B2Histone deacetylase inhibitorsERRANT GENE THERAPEUTICS LLC·Filed 2005·Granted Mar 8, 2011·0 cites·2 claims
- 1060US7193105B2Histone deacetylase inhibitors based on trihalomethylcarbonyl compoundsERRANT GENE THERAPEUTICS LLC·Filed 2003·Granted Mar 20, 2007·2 cites·18 claims
- 1156US7579372B2Histone deacetylase inhibitors based on alpha-ketoepoxide compoundsERRANT GENE THERAPEUTICS LLC·Filed 2005·Granted Aug 25, 2009·0 cites·4 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →